Treatment of iron deficiency in patients with chronic kidney disease: A prospective observational study of iron isomaltoside (NIMO Scandinavia) 
.

CONCLUSION: Iron isomaltoside shows a good effectiveness and safety profile in predialysis CKD patients. However, some patients did not receive adequate iron doses to allow for optimal correction of their iron deficiency anemia.
.
PMID: 30614439 [PubMed - as supplied by publisher]

Source: Clinical Nephrology - January 7, 2019 Category: Urology & Nephrology Authors: Jensen G, Gøransson LG, Fernström A, Furuland H, Christensen JH Tags: Clin Nephrol Source Type: research